Status:

COMPLETED

Endophenotype for Alcohol Misuse in Healthy Minority Populations

Lead Sponsor:

University of Pennsylvania

Conditions:

Healthy

Eligibility:

All Genders

21+ years

Phase:

PHASE4

Brief Summary

The purpose of the study is to understand the relationship between what an individual inherited from their family (genetics), how they respond and feel after drinking alcohol, and how they respond to ...

Detailed Description

We propose to test the degree to which specific genetic markers alter the relationship between subjective and objective measures of response to alcohol ingestion among non-alcohol dependent adults of ...

Eligibility Criteria

Inclusion

  • Male or female and 21 years of age or older
  • Drinks less than an average of 21 drinks/week with no more than 2 binge episodes per week
  • Of African descent by self report

Exclusion

  • Meets DSM-IV criteria for lifetime dependence on any substance other than nicotine
  • Subjects who test positive on the urine drug screen for opioids, cocaine, marijuana, or amphetamine at the screening visit
  • Subjects who meet current or lifetime DSM-IV criteria for bipolar affective disorder, schizophrenia, or any psychotic disorder
  • The presence of unstable or serious medical illness; including history of stroke, seizure disorder, severe liver disease (AST or ALT \> 5X normal at the time of randomization), or unstable cardiac disease
  • Needs treatment with any psychotropic medication (antidepressant, antipsychotic, benzodiazepine, or mood stabilizing medication)
  • Pre-menopausal female subjects who are pregnant, nursing, or not using a reliable method of contraception
  • Insulin-dependent diabetes
  • Any medical or psychological condition that could jeopardize the subject's safe participation in the trial as determined by the PI.

Key Trial Info

Start Date :

November 1 2005

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 1 2008

Estimated Enrollment :

43 Patients enrolled

Trial Details

Trial ID

NCT00256451

Start Date

November 1 2005

End Date

May 1 2008

Last Update

August 21 2019

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Pennsylvania Treatment Research Center

Philadelphia, Pennsylvania, United States, 19104